Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Ear, Nose and Throat Disorders
Published in: BMC Ear, Nose and Throat Disorders 1/2016

Open Access 01-01-2016 | Research article

Quality of life and symptoms before and after nasal septoplasty compared with healthy individuals

Authors: Vegard Bugten, Ann Helen Nilsen, Wenche Moe Thorstensen, Mads Henrik Strand Moxness, Marit Furre Amundsen, Ståle Nordgård

Published in: BMC Ear, Nose and Throat Disorders | Issue 1/2016

Login to get access

Abstract

Background

The goal of this study is to compare quality of life (Qol) and symptoms in 91 patients with a deviated nasal septum preoperatively and postoperatively with a control group of 93 healthy individuals.

Methods

All patients reported Qol on Sino-Nasal-Outcome-Test-20 (SNOT-20) and symptoms on visual analogue scale (VAS) preoperatively and 6 months after surgery and the results were compared with the controls.

Results

Mean SNOT-20 score improved from 1.8(SD0.9) preoperatively to 0.9(SD0.8) postoperatively (p < 0.000) but did not reach the same level as the controls 0.4(SD0.5). Septum surgery leads to a significant symptom improvement for all symptoms investigated (p < 0.000) on VAS. The patients reached the same level as the healthy controls in 6 of 11 symptoms (headache, facial pain, sneezing, trouble with rhinosinusitis, cough and snoring) but the patients group had significantly more trouble with nasal blockage (VAS 29 vs 9), change in sense of smell (VAS 12 vs5), nasal discharge (VAS 22 vs 11), oral breathing (VAS 23 vs 13) and reduced general health (VAS 12 vs 5) also postoperatively (p < 0.01). Sub analyses showed that allergic patients reported a VAS score of 36 (SD30) for nasal blockage and 17 (SD22) for facial pressure postoperatively versus 23(SD22) and 6(SD13) in non-allergic patients (p < 0.03 and p < 0.01). Patients with obstructive sleep apnea syndrome (OSAS) reported more trouble with snoring on VAS postoperatively than other patients, 42(SD28) versus 20(SD23) (p < 0.002).

Conclusion

Septoplasty leads to a highly significant improvement in Qol and symptoms. The patients do not reach the same level of Qol as healthy controls. All symptoms are reported as mild on VAS postoperatively.
Allergic patients tend to report more nasal blockage and facial pressure postoperatively than other patients and a focus on medical treatment should be kept also postoperatively. Patients with obstructive sleep apnea report more trouble with snoring postoperatively and alterative treatment options for snoring may be considered in these patients.
Appendix
Available only for authorised users
Literature
1.
Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, Bousquet PJ, Brozek G, Bruno A, Dahlen SE, et al. Chronic rhinosinusitis in Europe--an underestimated disease. A GA(2)LEN study. Allergy. 2011;66(9):1216–23.CrossRefPubMed
2.
Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–64.CrossRefPubMed
3.
Smith KD, Edwards PC, Saini TS, Norton NS. The prevalence of concha bullosa and nasal septal deviation and their relationship to maxillary sinusitis by volumetric tomography. Int J Dent 2010, 2010.
4.
Stallman JS, Lobo JN, Som PM. The incidence of concha bullosa and its relationship to nasal septal deviation and paranasal sinus disease. AJNR Am J Neuroradiol. 2004;25(9):1613–8.PubMed
5.
Siegel NS, Gliklich RE, Taghizadeh F, Chang Y. Outcomes of septoplasty. Otolaryngol Head Neck Surg. 2000;122(2):228–32.CrossRefPubMed
6.
Hytonen M, Blomgren K, Lilja M, Makitie AA. How we do it: septoplasties under local anaesthetic are suitable for short stay surgery; the clinical outcomes. Clin Otolaryngol. 2006;31(1):64–8.CrossRefPubMed
7.
Stewart MG, Smith TL, Weaver EM, Witsell DL, Yueh B, Hannley MT, Johnson JT. Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol Head Neck Surg. 2004;130(3):283–90.CrossRefPubMed
8.
Sundh C, Sunnergren O. Long-term symptom relief after septoplasty. Eur Arch Otorhinolaryngol. 2015;272(10):2871–75.CrossRefPubMed
9.
Karlsson TR, Shakeel M, Supriya M, Ram B, Ah-See KW. Septoplasty with concomitant inferior turbinate reduction reduces the need for revision procedure. Rhinology. 2015;53(1):59–65.PubMed
10.
Pynnonen MA, Kim HM, Terrell JE. Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in nonsurgical patients. Am J Rhinol Allergy. 2009;23(1):40–5.CrossRefPubMed
11.
Piccirillo JF, Merritt Jr MG, Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002;126(1):41–7.CrossRefPubMed
12.
Browne JP, Hopkins C, Slack R, Cano SJ. The Sino-Nasal Outcome Test (SNOT): can we make it more clinically meaningful? Otolaryngol Head Neck Surg. 2007;136(5):736–41.CrossRefPubMed
13.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12.PubMed
14.
Thorstensen WM, Bugten V, Sue-Chu M, Fossland NP, Romundstad PR, Steinsvag SK. Sino-nasal characteristics in asthmatic patients. Otolaryngol Head Neck Surg. 2012;147(5):950–7.CrossRefPubMed
15.
Randolph CC. Allergic rhinitis and asthma in the athlete. Allergy Asthma Proc. 2006;27(2):104–9.PubMed
Metadata
Title
Quality of life and symptoms before and after nasal septoplasty compared with healthy individuals
Authors
Vegard Bugten
Ann Helen Nilsen
Wenche Moe Thorstensen
Mads Henrik Strand Moxness
Marit Furre Amundsen
Ståle Nordgård
Publication date
01-01-2016
Publisher
BioMed Central
Published in
BMC Ear, Nose and Throat Disorders / Issue 1/2016
Electronic ISSN: 1472-6815
DOI
https://doi.org/10.1186/s12901-016-0031-7

Other articles of this Issue 1/2016

BMC Ear, Nose and Throat Disorders 1/2016 Go to the issue

Study protocol

Day-case stapes surgery: Day-case versus inpatient stapes surgery for otosclerosis: a randomized controlled trial

Debate

Review article: outcomes in endoscopic sinus surgery

Technical advance

Using mid infrared technology as new method for the determination of the dwell time of salivary substitutes on three dimensional gingiva models

Research article

Three year experience with the cochlear BAHA attract implant: a systematic review of the literature

Case report

Exogenous lipid pneumonia related to long-term use of Vicks VapoRub® by an adult patient: a case report

Reviewer acknowledgement

BMC ear, nose and throat disorders reviewer acknowledgment 2015